Fig. 1From: Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaSchematic diagram of continuous, maintenance, and intermittent treatment patterns. FOLFOX [oxaliplatin, 5-fluorouracil (5-FU) plus folinic acid], FOLFIRI (irinotecan, 5-FU plus folinic acid), CapeOx (capecitabine plus oxaliplatin), and FOLFOXIRI (oxaliplatin, irinotecan, 5-FU plus folinic acid) regimens were used for combination chemotherapy. Bevacizumab or cetuximab was used as targeted agents. CR complete remission, PR partial remission, SD stable diseaseBack to article page